TSO

TriSourceObserve

Slow journalism for technology, industry, and capital.

Stories

Capital Flow

Shows how policy, balance sheets, market structure, and investor expectations transmit change across industries.

AllMacro InsightsCorporate StrategyFinTech & Future AssetsSector Deep-dive
TSO / High confidence
Capital FlowSector Deep-dive

Kailera Therapeutics Completes $625 Million IPO, Advancing Financing for Obesity Drug Pipeline

Kailera Therapeutics completed its IPO in April 2026, pricing shares at $16 each and raising $625 million. Three sources consistently confirm the fundraising size, offering price, and the company’s focus on obesity biopharmaceuticals. However, details such as the number of shares sold, specific use of proceeds, and listing arrangements appear only in individual sources and should be treated separately from the confirmed facts.

Apr 22, 2026
Read analysis
TSO / High confidence
Capital FlowSector Deep-dive

Japanese agritech startup Culta raises $4.5 million in pre-Series A funding, focusing on an AI non-GMO breeding platform

Japanese agritech startup Culta has secured 7 million yen, or about $4.5 million, in pre-Series A funding to expand its AI-driven non-GMO crop breeding platform. All three sources confirm the funding amount and company name; one source says its core innovation is cutting the breeding cycle from more than 10 years to about two years. The provided sources do not mention investors, round structure details, or broader business metrics.

Apr 20, 2026
Read analysis